Literature DB >> 9156041

Iodine insufficiency and neonatal hyperthyrotropinaemia in Hong Kong.

A W Kung1, T T Lao, L C Low, R W Pang, J D Robinson.   

Abstract

OBJECTIVES: 23% of the neonatal hypothyroidism in Hong Kong is transient. The present study aims to evaluate iodine excretion in healthy pregnant women in Hong Kong and to determine whether iodine insufficiency may occur in the local population to account for the type of neonatal thyroid dysfunction seen in our screening programme.
SUBJECTS: Pilot screening of urinary iodine excretion was determined in 253 healthy pregnant women between 32 and 36 weeks gestation. Fetal and maternal thyroid function in relation to urinary iodine excretion was evaluated in another 55 pregnant women who had given birth to infants with cord blood TSH > or = 16 mIU/I (95th percentile of the cord blood TSH screening programme) and the results were compared to a control group of 160 healthy women whose infants had cord blood TSH < 16 mIU/I.
RESULTS: Using a cut-off value of 0.79 mumol/l, a level as defined by WHO as iodine deficiency, we found that 35.8% of the pregnant women had urinary iodine concentrations below this cut off value. We demonstrated that the existence of borderline iodine supply affected the maternal and fetal thyroid function as evidenced by (i) a negative correlation between maternal TSH and urinary iodine concentration, (ii) higher cord blood TSH in those infants whose mothers had a low urinary iodine concentration as compared to those in whose mothers it was normal, (iii) women who had given birth to infants with cord blood TSH > or = 16 mIU/I had lower urinary iodine concentrations and serum fT4 levels as compared to mothers who had given birth to infants with normal cord TSH levels, and their offspring also had higher cord blood thyroglobulin levels.
CONCLUSION: Although Hong Kong is not a goitrous area, borderline iodine deficiency exists. Iodization of salt in our community could obviate the necessity for iodine supplements in pregnant women and other at-risk groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9156041     DOI: 10.1046/j.1365-2265.1997.1310960.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

Review 1.  The changing epidemiology of iodine deficiency.

Authors:  Mu Li; Creswell J Eastman
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

2.  Update on Neonatal Isolated Hyperthyrotropinemia: A Systematic Review.

Authors:  Ana E Chiesa; Mariana L Tellechea
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-18       Impact factor: 5.555

3.  Neonatal thyroid-stimulating hormone concentrations in Belgium: a useful indicator for detecting mild iodine deficiency?

Authors:  Stefanie Vandevijvere; Wim Coucke; Jean Vanderpas; Caroline Trumpff; Maarten Fauvart; Ann Meulemans; Sandrine Marie; Marie-Françoise Vincent; Roland Schoos; François Boemer; Timothy Vanwynsberghe; Eddy Philips; François Eyskens; Brigitte Wuyts; Valbona Selimaj; Bart Van Overmeire; Christine Kirkpatrick; Herman Van Oyen; Rodrigo Moreno-Reyes
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

4.  Universal salt iodization is successful in Kashmiri population as iodine deficiency no longer exists in pregnant mothers and their neonates: Data from a tertiary care hospital in North India.

Authors:  Bashir Ahmed Charoo; Riyaz Ahmed Sofi; Sobia Nisar; Parvaiz A Shah; Shenaz Taing; Henaan Jeelani; Fayaz Ahmed; Shameem Parveen; Zaffar Amin Shah; Syed Mudasir; Masood Malik; Mohd Ashraf Ganie
Journal:  Indian J Endocrinol Metab       Date:  2013-03

5.  Newborn Screening for Thyroid-stimulating Hormone as an Indicator for Assessment of Iodine Status in the Republic of Macedonia.

Authors:  Violeta Anastasovska; Mirjana Kocova
Journal:  J Med Biochem       Date:  2016-11-02       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.